ErbB2 is required for ductal morphogenesis of the mammary gland

Department of Pathology, Yale University School of Medicine, New Haven, CT 06520-8023, USA.
Proceedings of the National Academy of Sciences (Impact Factor: 9.81). 01/2005; 101(49):17138-43. DOI: 10.1073/pnas.0407057101
Source: PubMed

ABSTRACT The ERBB2/HER2/NEU receptor tyrosine kinase gene is amplified in up to 30% of human breast cancers. The frequent and specific selection of this receptor kinase gene for amplification in breast cancer implies that it has important normal functions in the mammary gland. To investigate the functions of ErbB2 during normal mouse mammary gland development, we transplanted mammary buds from genetically rescued ErbB2(-/-) embryos that express ErbB2 in the cardiac muscle. ErbB2(-/-) mammary buds transplanted to a wild-type mammary fat pad support outgrowth of an epithelial tree that advances only slowly through the mammary fat pad at puberty. This penetration defect is associated with structural defects in terminal end buds, characterized by a decrease in body cell number, an increased presence of cap-like cells in the prelumenal compartment, and the presence of large luminal spaces. Lobuloalveolar development was not affected in glands that developed from ErbB2(-/-) transplanted tissue. The results may have implications for the aggressive phenotypes associated with ERBB2-overexpressing mammary carcinomas.

Download full-text


Available from: Gary Bellinger, Aug 10, 2015
  • Source
    • "ErbB3 and ErbB4 are normally absent during early ductal development (Schroeder and Lee 1998), but might have been up-regulated in the absence of EGFR. Moreover, epithelial expression of ErbB2 is necessary for ductal extension (Jackson-Fisher et al. 2004; Andrechek et al. 2005). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Human mammary glands arise from multipotent progenitor cells, which likely respond both to cell-autonomous and to extrinsic cues. However, the identity of these cues and how they might act remain unclear. We analyzed HER1 ligand effects on mammary morphogenesis using a three-dimensional organoid model generated from human breast tissue that recapitulates both qualitatively and quantitatively the normal ductal network in situ. Strikingly, different HER1 ligands generate distinct patterns of cell fate. Epidermal growth factor (EGF) causes a massive expansion of the myoepithelial lineage. Amphiregulin, in contrast, enables normal ductal development. These differences cannot be ascribed to preferential apoptosis or proliferation of differentiated cell populations, but are dependent on HER1 signal intensity. Inhibition of the extracellular signal-regulated kinase 1/2 (ERK1/2) effector RSK prevents the EGF-induced myoepithelial expansion. Notably, mouse mammary organoids are much less responsive to HER1 ligands. Little is known about the myoepithelial lineage or about growth factor effects on mammary progenitor differentiation, and our studies provide an important window into human mammary development that reveals unexpected differences from the mouse model.
    Genes & development 08/2011; 25(15):1641-53. DOI:10.1101/gad.2025611 · 12.64 Impact Factor
  • Source
    • "Exogenous estradiol induces tyrosine phosphorylation of EGFR as well as ErbB2 in ovariectomized mice, which is also observed in pubertal mammary glands (Sebastian et al. 1998). Intriguingly, ErbB2, which heterodimerizes with EGFR or other ErbB receptors, is required in the epithelium for normal ductal development (Jackson-Fisher et al. 2004; Andrechek et al. 2005), whereas ErbB4 is required for lobuloalveologenesis during pregnancy (Tidcombe et al. 2003). Factors that play important local functions in maintaining the TEB or ductal morphology include netrin-1 and its receptor neogenin (Srinivasan et al. 2003) and a cell surface morphogen epimorphin (Radisky et al. 2003). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The adult mammary structure provides for the rapid growth, development, and immunological protection of the live-born young of mammals through its production of milk. The dynamic remodeling of the branched epithelial structure of the mammary gland in response to physiological stimuli that allow its programmed branching morphogenesis at puberty, cyclical turnover during the reproductive cycle, differentiation into a secretory organ at parturition, postlactational involution, and ultimately, regression with age is critical for these processes. Extracellular metalloproteinases are essential for the remodeling programs that operate in the tissue microenvironment at the interface of the epithelium and the stroma, coupling form with function. Deregulated proteolytic activity drives the transition of a physiological mammary microenvironment into a tumor microenvironment, facilitating malignant transformation.
    Cold Spring Harbor perspectives in biology 11/2010; 3(4). DOI:10.1101/cshperspect.a004333 · 8.23 Impact Factor
  • Source
    • ", because there is a local need for HER inhibition in differentiating ductal epithelia [40]. HST/HER2 transcript ratios in tissues were comparable but generally lower than those described in cell lines [15], a result probably due to tissue cell heterogeneity. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Herstatin (HST) is an alternatively spliced HER2 product with growth-inhibitory properties in experimental cancer systems. The role of HST in adult human tissues and disease remains unexplored. Here, we investigated HST expression at the mRNA and protein (immunohistochemistry [IHC]) level in parallel with parameters reflecting HER activation in 187 breast carcinomas and matched noncancerous breast tissues (NCBT). Noncancerous breast tissues demonstrated the highest HST/HER2 transcript ratios corresponding to a few positive epithelial and stromal cells by IHC. Although HST/HER2 transcript ratios in tumors were inversely associated with HER2 IHC grading (P = .0048 for HER2 IHC-1+ and P = .0006 for HER2 IHC-2+ vs HER2-negative tumors), relative HST expression within the same tumor/NCBT system remained constant. HST/HER2 ratios did not predict the presence of HST protein, which was found in 46 (25%) of 187 tumors. A subgroup of HER2 IHC-3+ tumors exhibited high HST/HER2 transcript ratios, strong HST protein positivity, and cytoplasmic phospho-Akt/PKB and p21(CIP1/WAF1) localization. In conclusion, HST may act as a paracrine factor in the adult breast. Because HST is described as an endogenous pan-HER inhibitor, the presence of this protein in breast carcinomas may portent the inefficiency of exogenous efforts to block HER2 dimerization, whereas its absence may justify such interventions.
    Neoplasia (New York, N.Y.) 08/2008; 10(7):687-96. DOI:10.1593/neo.08314 · 5.40 Impact Factor
Show more